Further Information
COL4A3BP, collagen, type IV, alpha 3 (Goodpasture antigen) binding protein , CERT, CERTL, FLJ20597, GPBP , STARD11, Goodpasture antigen-binding protein, START domain containing 11, alpha 3 type IV collagen binding protein, ceramide transporter,
Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot:Approx 60-65kDa band observed in Mouse Heart lysates (calculated MW of 71.1kDa according to Mouse NP_075909.1). An additional band of unknown identity was also consistently observed at 25kDa. Both bands were successfully blocked by incubation with the immunising peptide. Recommended concentration: 0.3-1ug/ml. Peimary incubation 1 hour at room temperature.
- Swanton C, Marani M, Pardo O, Warne PH, Kelly G, Sahai E, Elustondo F, Chang J, Temple J, Ahmed AA, Brenton JD, Downward J, Nicke B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer. 2007 Jun;11(6):498-512.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Human
The immunogen for this antibody is: DHDSAPLNNRC
10087
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
COL4A3BP
Homo sapiens
Liquid
NP_005704.1, NP_112729.1
5031717
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognise both reported isoforms (NP_005704.1 and NP_112729.1)
Q9Y5P4